Radiochromic film for spot-scanning QA provides high spatial resolution and efficiency gains from one-shot irradiation for multiple depths. However, calibration can be a tedious procedure which may limit widespread use. Moreover, since there may be an energy dependence, which manifests as a depth dependence, this may require additional measurements for each patient. We present a one-scan protocol to simplify the procedure. A calibration using an EBT3 film, exposed by a 6-level step-wedge plan on a Proteus A clinical prostate + nodes plan was used for validation. The planar doses at selected depths were measured with EBT3 films and analyzed using one-scan protocol (one-scan digitization of QA film and at least one film exposed to a known dose). The gamma passing rates, dose-difference maps, and profiles of 2D planar doses measured with EBT3 film and IBA MatriXX-PT, versus the RayStation TPS calculations were analyzed and compared. The EBT3 film measurement results matched well with the TPS calculation data with an average passing rate of ~95% for 2%/2 mm and slightly lower passing rates were obtained from an ion chamber array detector. We were able to demonstrate that the use of a proton step-wedge provided clinically acceptable results and minimized variations between film-scanner orientation, inter-scan, and scanning conditions. Furthermore, for relative dosimetry (calibration is not done at the time of experiment), it could be derived from no more than two films exposed to known doses (one could be zero) for rescaling the master calibration curve at each depth. The sensitivity of the calibration to depth variations has been explored. One-scan protocol results appear to be comparable to that of the ion chamber array detector. The use of a proton step-wedge for calibration of EBT3 film potentially increases efficiency in patient-specific QA of proton beams.
(RBE) (relative biological effectiveness) for proton energies of 170 -200 MeV. A clinical prostate + nodes plan was used for validation. The planar doses at selected depths were measured with EBT3 films and analyzed using one-scan protocol (one-scan digitization of QA film and at least one film exposed to a known dose). The gamma passing rates, dose-difference maps, and profiles of 2D planar doses measured with EBT3 film and IBA MatriXX-PT, versus the RayStation TPS calculations were analyzed and compared. The EBT3 film measurement results matched well with the TPS calculation data with an average passing rate of ~95% for 2%/2 mm and slightly lower passing rates were obtained from an ion chamber array detector. We were able to demonstrate that the use of a proton step-wedge provided clinically acceptable results and minimized variations between film-scanner orientation, inter-scan, and scanning conditions. Furthermore, for relative dosimetry (calibration is not done at the time of experiment), it could be derived from no more than two films exposed to known doses (one could be zero) for rescaling the master calibration curve at each depth. The sensitivity of the calibration to depth variations has been explored. One-scan protocol results appear to be comparable to that of the ion chamber array detector. The use of a proton step-wedge for calibration of EBT3 film potentially increases efficiency in patient-specific QA of proton beams.
Introduction
Owing to its dosimetric characteristics, particularly finite range, proton therapy provides a potentially favorable treatment option for many cancer patients [1] [2]. Protons show an increasing energy deposition with penetration distance leading to a maximum dose (the Bragg peak) near the end of range of the proton beam. A weighted sum of individual Bragg peaks of different energies can be used to generate a uniform dose plateau or spread-out Bragg peak (SOBP), which in turn, can be overlaid over the target during treatment planning. The SOBP is characterized by its range and width, or modulation [3] . Delivery of an SOBP has used different techniques including most commonly passive scattering [4] [5] as well as uniform scanning [6] [7] .
More recently, spot scanning or pencil beam scanning (PBS) has emerged as a delivery technique [8] [9] . Unlike scattered beams, in which the dose is shaped by a selection of the appropriate range and modulation and shaped with a customized compensator and aperture, in spot scanning, the beam is delivered and shaped by scanning individually weighted spots to a radiological depth. The energy is then changed and the next layer is scanned. Analogous to x-ray treatment planning, scatter beams are forward planned in 3D, whereas spot scanning is inversely planned [10] [11] .
The current standard of patient-specific QA for spot scanning proton therapy is to perform measurements using a chamber array at different depths followed by a 2D or 3D gamma analysis [12] [13] . Radiochromic film for spot scanning QA provides high spatial resolution and efficiency gains from one-shot irradiation at multiple depths. The use of radiochromic film for protons has been reported in a variety of investigations [14] - [22] . However, calibration can be a tedious procedure that may reduce widespread use. Moreover, since there may be an energy dependence, which manifests as a depth dependence, this may require additional measurements for each patient [23] . We applied the one-scan protocol [24] to simplify the procedure. Briefly, this approach requires only a single calibration exposure to a known dose of one film and a single scan of the QA film thereby vastly simplifying what the previous approach of irradiating multiple films for calibration each time. This study aims to investigate the effectiveness of one-scan protocol on proton dosimetry, focusing attention on its application to spot scanning patient-specific QA.
Materials and Methods
Irradiations were performed using a spot scanning beam delivery on a Proteus ® PLUS proton system (IBA, Belgium) at the ProCure Proton Therapy Center in Somerset, NJ. Typical energy ranges from the nozzle vary from ~100 to 230 MeV, however, much lower effective energies can be obtained for treating superficial depths using a range shifter. The details of the beam delivery system are described in a separate study [25] . A clinical treatment plan for prostate with seminal-vesicles and pelvis-nodal - [33] and it has been established that the effect is highest for lower (<11 MeV) proton energies [28] . However, for spot scanning beams, there may be a larger distribution of energies used to irradiate the PTV which could make accounting for LET corrections quite variable. To assess the depth (energy) dependence, we performed gamma analysis using calibration films at different depths. The films were analyzed using One-scan protocol (one-scan digitization of QA film and at least one film exposed to a known dose). We used the 180 cGy(RBE) calibration dose and the zero dose to rescale the dose response of the patient film. This is analogous to the absolute dose calibration for diode array or ion chamber array detectors before the patient-specific QA takes place. The gamma passing rates, dose-difference maps, and profiles of 2D planar doses measured with EBT3 film and IBA MatriXX-PT, versus the RayStation TPS calculations were analyzed and compared.
Results
The dose-response data could be fit to a set of related rational functions leading to the description of a generic calibration curve for a given film lot [34] . One generic calibration curve was generated using the scanned step-wedge film at each depth ( Figure 3 ). For comparison of MatriXX-PT, a similar dose map and step-level were used. The dose-response data for a specific film lot, scanner, and scanning conditions could be derived from two films exposed to known doses including zero dose. For relative dosimetry when the calibration is not done at the time of patient QA, two-point rescaling could be applied to rebuild the master calibration curve at each depth. Again, the selection of the two-point doses (one of them could be zero) depends on the maximum dose level on the plane of patient QA film. These calibration films must be exposed at the same time as the QA film in order to be compliant with the One-scan protocol. Each QA film was scanned together with an exposed reference film (irradiated within minutes of the QA films) and a piece of unexposed film. The EBT3 film measurement results matched well with the TPS calculation data with an average passing rate of ~95% for 2%/2 mm and slightly lower passing rates were obtained from an ion chamber array detector (Table 2) . To explore the depth dependence, we have applied different combinations of calibration curves and patient QA films at 3 different depths to assess the effect. Table 3 demonstrates the highest passing rate occurred when using calibration and QA film at the same depth; therefore it suggests having a different calibration function at a different depth.
Discussion
Radiochromic film dosimetry in low-energy proton or ion beams requires a cor-rection of the LET dependent film response [35] [36] . Radiochromic film can be used as a reference dosimeter for biomedical experiments with low-energy proton beams if appropriate LET corrections are applied [36] . There are numerous researchers reported that under-response of radiochromic film in the presence of proton SOBPs which could be defined as "quenching effect" of the dosimeter in the region [26] - [33] [35] [36] [37] . "Quenching" is said to occur when, for a given physical dose, a dosimeter not limited to radiochromic film gives a lower output reading for radiation with high LET than for the same dose of low LET radiation. The effects are particularly noticeable for measurements made at the Bragg peak in proton treatments [38] . Quenching of dosimeter response is a major issue in the measurement of the radiation dose from proton and other ion beams. The quenching effect of EBT3 film is the highest at the lowest initial energy of the clinical beams, a phenomenon related to the corresponding higher LET in the film sensitive layer [35] . A possible reason for this is attributed to the shape and arrangement of the monomer particles being different in the active components of EBT. It is suggested that the polymer yield factor is the dominant factor causing the LET quenching effect [29] . continuously (lowest at Bragg peak and highest effect in depth dependence). The energy response is also dependent on the position of the Bragg peak [6] .
The film orientation relative to the proton beam direction also plays an important role in dosimetry due to radiation interaction's causing polymerization in radiochromic film [7] . The parallel orientation was found to be superior as one can get an entire 2D data set from one single film. When using a single film piece positioned parallel to the proton beam axis, it is recommended to tilt the film plane at different degrees (1˚ -5˚) from the proton beam axis or the film can be kept in water [6] [18]. The film had sufficient width so that water in the film would not cause additional perturbation. In our work, we have positioned the EBT3 film perpendicular to the beam axis, calibrated the step-wedge film with the mixed proton energies at each depth, used one-scan protocol for film analysis to eliminate the inter-scan variability and corrected for post-exposure density growth. The film results are comparable with the ion chamber array measurements as respect to the TPS calculations.
Conclusion
The use of a proton step-wedge for calibration of EBT3 film appears to increase the efficiency. The sensitivity of the calibration to depth variations has been explored. However, the step-wedge approach should be limited to film dosimetry at the range which is not at the distal edge of SOBP. The LET dependence of EBT3 needs to be incorporated in the process to improve the accuracy of film dosimetry at lower proton energies or when the film is parallel to the beam axis.
